Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MotherEarth Biotech manufactures and supplies bacterial cultures and bio-cultures used in effluent treatment plants (ETP), sewage treatment plants (STP), common effluent treatment plants (CETP), bioremediation, municipal solid waste management, odor control, biofertilizers for agriculture, and animal feed. The company has state-of-the-art R&D facilities focused on quality assurance and regulatory compliance. Their products are available in both liquid and powder forms under sub-brands such as EffuTreat, SepTreat, CompTreat/Nature Protector/Silage Culture/Biofertilizer. No clinical trial data or human therapeutic results are reported as their focus is on environmental biotech solutions rather than pharmaceuticals or direct healthcare interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mother Nature.